All Articles

Chip Wilson nominates three directors in a bid to remake Lululemon's board, criticizing its leadership and demanding a return to product innovation.

A new AI assistant is being piloted in the UAE, promising to cut doctor paperwork by 50% and give patients more face-to-face attention.

Setrusumab, a promising drug for Osteogenesis Imperfecta, failed to reduce fractures in key trials, triggering a market collapse and strategic overhaul.

Verisk terminates its $2.35B AccuLynx acquisition after FTC delays, triggering a $1.5B debt redemption and a potential legal battle with the spurned firm.

The investment firm sheds its medical focus, adopting a new name and a broader mandate to chase cross-sector opportunities in the booming AI market.

A pivotal trial for an acute myeloid leukemia drug is delayed for a promising reason: patients are surviving longer than anticipated, fueling cautious optimism.

With its 'Results Your Way' plan, the fitness giant is rolling out personalized coaching, recovery zones, and Pilates to compete in a changing market.

A Vikings-Packers showdown becomes a lifeline for Minnesotans as Land O'Lakes pledges one ton of food for every point scored, fighting winter hunger.

The InsurTech firm is shedding non-core units to slash debt by over 50% and double down on its AI platforms, RELI Exchange and 5minuteinsure.com.

Israeli innovator Foresight gets a major nod from Audi, showcasing its all-weather 3D vision system that could redefine autonomous vehicle safety.

Cleveland expands its AI security robot program, citing reduced crime. But as other cities watch, questions of cost, privacy, and effectiveness emerge.

Fresh off a volatile IPO, Malaysian hotpot chain CCH Holdings plans a massive 2026 expansion. Can this small-cap company conquer the U.S. and Africa?

A new toothbrush using safe microcurrents claims to remove 6x more plaque and cut gum inflammation. Does the science behind this oral care revolution hold up?

In a bold strategic shift, private jet operator Volato is entering the national security-focused critical minerals sector, guided by a seasoned financier.

TRON founder Justin Sun injects $18M into Nasdaq-listed Tron Inc., bolstering its crypto treasury and cementing its unique dual business model.

Sofie Biosciences begins late-stage trials for a novel PET scan targeting aggressive gastrointestinal cancers, a breakthrough that could redefine detection.

A critical labor dispute at Canada’s largest propane export terminal is over, but not before testing the resilience of a key global energy supply chain.

With promising new drugs for obesity and liver disease, clinical-stage MetaVia steps into the spotlight at a key industry conference, facing giants and high hopes.

As 374Water pushes its waste-destroying tech to market, a new board member with deep financial expertise and a history as a long-term investor joins.

The cleantech firm hits key milestones in German and Italian energy projects while its unconventional portfolio expands into biotech and agritech.